A method for treating a patient having Metabolic Syndrome comprising
Primary Insulin Resistance and exhibiting lipoprotein aberrations or
hypertension comprises administering to said patient human growth hormone
or a functional analog thereof in an amount effective for decreasing
lipoprotein aberrations or hypertension of said patient.